AboutTermsPrivacyContact
 
Updating
WolverHeme Happy Hour

WolverHeme Happy Hour

Bernard Marini, Anthony Perissinotti, et al.
Released: 2022-04-22
© Bernard Marini, Anthony Perissinotti, et al.
WolverHeme Happy Hour - QR Code
Free0%
4 Episodes
Audio
Listen on Apple Podcasts
Free0%
4 Episodes
Audio
Listen on Apple Podcasts
Released: 2022-04-22
© Bernard Marini, Anthony Perissinotti, et al.
Most Recent Episode
Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

Time: 50:03
Play
In part two of this two-part episode, Bernie Marini and Anthony Perissinotti discuss the use of rituximab in acute lymphoblastic leukemia (ALL), based on the recent publication of the UKALL14 study (Marks, et al. Lancet Haematol, 2022): https://pubmed.ncbi.nlm.nih.gov/35358441/. We also discuss the previously published GRAALL study that evaluated rituximab in ALL (Maury, et al. NEJM, 2016, https://pubmed.ncbi.nlm.nih.gov/27626518/), and what we can conclude from the literature to date. The data surprises us, and makes us question our own practices!
Episode ID: 1000558423438
GUID: eb7420a5-124d-430e-ba19-06448724a544
Release Date: 22/04/2022, 23:01:18

Description

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks!
Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Feed URL

https://anchor.fm/s/88fe6770/podcast/rss

Apple Podcasts: Customer Reviews

No Entry